Cost Effectiveness Analysis Of Abiraterone Acetate As Treatment For Metastatic Castration Resistant Prostate Cancer After Failure Of Docetaxel Using Data From Real Life Treatment Praxis In Sweden
May 1, 2013, 00:00
10.1016/j.jval.2013.03.655
https://www.valueinhealthjournal.com/article/S1098-3015(13)00726-2/fulltext
Title :
Cost Effectiveness Analysis Of Abiraterone Acetate As Treatment For Metastatic Castration Resistant Prostate Cancer After Failure Of Docetaxel Using Data From Real Life Treatment Praxis In Sweden
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00726-2&doi=10.1016/j.jval.2013.03.655
First page :
A134
Section Title :
Cancer
Open access? :
No
Section Order :
204